Bronchopro Retard Cap

Bronchopro Retard Cap

Description:

Bronchopro Retard 75 mg capsules are a prescription mucolytic medicine containing ambroxol, formulated in a prolonged-release (retard) capsule for sustained action. It is used to treat productive (chesty) cough associated with acute and chronic respiratory diseases where thick, sticky mucus is a problem, such as chronic bronchitis, emphysema with bronchitis, and other chronic inflammatory pulmonary conditions. By thinning and loosening mucus in the airways, Bronchopro Retard Cap facilitates easier expectoration, improves breathing comfort, and supports better lung function over an extended period of time.

Indications:

• Mucolytic treatment in acute and chronic respiratory diseases associated with abnormal mucus secretion and impaired mucus transport.
• Chronic bronchitis and emphysema with bronchitis.
• Pneumoconiosis and other chronic inflammatory pulmonary conditions with viscous sputum.
• Tracheobronchitis (inflammation of the trachea and bronchi) with productive cough.
• Bronchiectasis with excessive mucus production.
• Bronchitis with bronchospasm, including in patients with asthma, as adjunctive therapy to improve mucus clearance.
• Relief of chest congestion by thinning and mobilizing thick bronchial secretions.

Active Ingredients / Key Components:

• Ambroxol hydrochloride – 75 mg per prolonged-release capsule.
• Excipients: The full list of inactive ingredients (capsule shell components, fillers, etc.) is not available in the provided information. Please refer to the package leaflet for complete excipient details.

Dosage & Administration / How to Use:

• Adults and adolescents (as directed by physician): The usual total daily dose of ambroxol for mucolytic therapy is 30–120 mg/day in 2–3 divided doses. Bronchopro Retard 75 mg is a prolonged-release formulation; the exact dose and frequency (often 1 capsule once daily or as prescribed) must be determined by your doctor based on your condition and response.
• Swallow the capsule whole with a sufficient amount of water. Do not crush, chew, or open the capsule, as this may affect the prolonged-release properties.
• Can be taken with or without food, unless otherwise directed by your healthcare provider.
• Use for the shortest duration necessary to control symptoms, or as prescribed by your physician.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed dose.
• Not recommended for children unless specifically prescribed by a pediatrician and according to age-appropriate dosing guidelines.

Clinical Benefits:

• Helps liquefy and break down thick, tenacious mucus in the airways, making it easier to cough up.
• Supports improved clearance of bronchial secretions, helping to relieve chest congestion and facilitate freer breathing.
• Prolonged-release (retard) capsule provides sustained ambroxol levels, offering longer-lasting mucolytic effect with convenient dosing.
• Adjunctive support in chronic respiratory conditions such as chronic bronchitis, emphysema with bronchitis, and bronchiectasis to enhance mucus drainage.
• May help reduce the frequency and severity of productive cough associated with excessive mucus.

Warnings & Contraindications:

• Do not use if you are allergic (hypersensitive) to ambroxol or any of the other ingredients in the product.
• Use with caution in patients with a history of peptic ulcer disease or severe hepatic or renal impairment; dose adjustment or closer monitoring may be required.
• Patients with rare hereditary conditions that may be incompatible with certain excipients (e.g., lactose intolerance, if present) should consult their doctor before use and check the full excipient list in the leaflet.
• Consult your doctor before use if pregnant or planning pregnancy. Ambroxol should be used during pregnancy only if clearly needed and under medical supervision.
• Caution is advised in breastfeeding women; consult your doctor before use, as ambroxol is excreted in breast milk.
• Seek medical advice if cough persists for more than a few days, is accompanied by high fever, blood in sputum, or signs of severe respiratory distress.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.
• Do not exceed the recommended dose. Misuse or overuse may increase the risk of side effects.

Side Effects:

• Common side effects may include gastrointestinal discomfort such as nausea, vomiting, stomach pain, indigestion, or diarrhea.
• Occasional side effects can include dry mouth or throat, altered taste, or mild skin reactions such as rash or itching.
• Rare but serious allergic reactions may occur, including swelling of the face, lips, tongue, or throat, severe skin reactions, or difficulty breathing. Discontinue use and seek immediate medical attention if these occur.
• If you experience persistent or severe side effects, stop taking the medicine and consult your doctor or pharmacist.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date stated on the package. Store at or below the temperature specified on the product carton (exact temperature range is not available in the provided information; refer to the original packaging).

Specifications:

• Form: Prolonged-release capsule.
• Strength: 75 mg ambroxol hydrochloride per capsule.
• Pack size: 10 capsules per pack.
• Intended use: Mucolytic medicine for adults and adolescents as prescribed.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.